Surveillance of Non Nucleoside Reverse Transcriptase Inhibitors Transmitted Drug Resistance in Spain. ¿Do we need baseline resistance results prior to starting a Doravirine based first line regimen?

Optimizing HIV prevention using phylogenetic analysis in Spain

Tracing the geographical origin of HIV-1 infection and patterns of epidemic spread among migrants in Europe by means of molecular epidemiology

Vigilancia de la transmisión de resistencias a antirretrovirales y de la introducción de subtipos no B en CoRIS

Effectiveness of transmitted drug resistance testing overall and in individuals with late HIV diagnosis

Evaluation of the virological response to first -line HAART containing a ritonavir-boosted protease inhibitor (PI/r) among patients infected with HIV-1 subtypes CRF02_AG, A, C or F compared with subtype B infected patients

Vigilancia de la Transmisión de Resistencias a los inhibidores de la integrasa en España

Resistance following virologic failure with tenofovir +NNRTI containing antiretroviral regimens: a global patient level meta-analysis

Determinación de resistencias primarias a Rilpivirina en la Cohorte de Adultos Seropositivos de la Red de Investigación en SIDA (CoRIS)

Caracterización del tropismo viral en los pacientes de la cohorte RIS